Exploring the repository of de novo-designed bifunctional antimicrobial peptides through deep learning.

Journal: eLife
PMID:

Abstract

Antimicrobial peptides (AMPs) are attractive candidates to combat antibiotic resistance for their capability to target biomembranes and restrict a wide range of pathogens. It is a daunting challenge to discover novel AMPs due to their sparse distributions in a vast peptide universe, especially for peptides that demonstrate potencies for both bacterial membranes and viral envelopes. Here, we establish a de novo AMP design framework by bridging a deep generative module and a graph-encoding activity regressor. The generative module learns hidden 'grammars' of AMP features and produces candidates sequentially pass antimicrobial predictor and antiviral classifiers. We discovered 16 bifunctional AMPs and experimentally validated their abilities to inhibit a spectrum of pathogens in vitro and in animal models. Notably, P076 is a highly potent bactericide with the minimal inhibitory concentration of 0.21 μM against multidrug-resistant , while P002 broadly inhibits five enveloped viruses. Our study provides feasible means to uncover the sequences that simultaneously encode antimicrobial and antiviral activities, thus bolstering the function spectra of AMPs to combat a wide range of drug-resistant infections.

Authors

  • Ruihan Dong
    PTN Graduate Program, Academy for Advanced Interdisciplinary Studies, Peking University, Beijing, 100871, China.
  • Rongrong Liu
    Department of Microbiology, School of Basic Medicine, Fourth Military Medical University, Shaanxi, China.
  • Ziyu Liu
    Department of Gastroenterology, Beijing Xuanwu Hospital, Capital Medical University, Beijing, China.
  • Yangang Liu
    Department of Microbiology, Second Military Medical University, Shanghai, China.
  • Gaomei Zhao
    State Key Laboratory of Trauma and Chemical Poisoning, Institute of Combined Injury of PLA, College of Preventive Medicine, Third Military Medical University (Army Medical University), Chongqing, China.
  • Honglei Li
    Tianjin Cancer Hospital Airport Hospital, Tianjin, China.
  • Shiyuan Hou
    Department of Microbiology, School of Basic Medicine, Fourth Military Medical University, Shaanxi, China.
  • Xiaohan Ma
    Department of Gastroenterology, The First Affiliated Hospital of Anhui Medical University, Hefei 230032, China.
  • Huarui Kang
    Department of Microbiology, School of Basic Medicine, Fourth Military Medical University, Shaanxi, China.
  • Jing Liu
    Department of Ophthalmology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China.
  • Fei Guo
    School of Electronic Information Engineering, Tianjin University, Tianjin 300072, China. Electronic address: gfjy001@yahoo.com.
  • Ping Zhao
    Department of Information, Research Institute of Field Surgery, Daping Hospital of Army Medical University, 10 Changjiang Access Road, Chongqing, 400042, China.
  • Junping Wang
    Foundation Department, Huaibei Vocational and Technical College, Huaibei 23500, China.
  • Cheng Wang
    Department of Pathology, Dalhousie University, Halifax, NS, Canada.
  • Xingan Wu
    Department of Microbiology, School of Basic Medicine, Fourth Military Medical University, Shaanxi, China.
  • Sheng Ye
    Hefei National Laboratory for Physical Science at the Microscale, Department of Chemical Physics, University of Science and Technology of China, Hefei, Anhui 230026, China.
  • Cheng Zhu
    Translational Sciences, Sanofi US, Framingham, MA, 01701, USA. Cheng.Zhu@sanofi.com.